Serge Messerlian, Teon Therapeutics CEO
March 8, 2022 02:12 PM ESTUpdated 03:18 PM
People

From J&J on­col­o­gy chief to tiny biotech start­up CEO? Serge Messer­lian talks about his big ca­reer change­up

Paul Schloesser

Associate Editor

San Fran­cis­co-based Teon Ther­a­peu­tics got it­self a new CEO — in a tran­si­tion from Big Phar­ma in­to the world of biotech.

But what sparked that tran­si­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times